Related Experiment Video
Updated: Oct 26, 2025
08:25
Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
9.3K
Perimyocarditis in Adolescents After Pfizer-BioNTech COVID-19 Vaccine
Eric Tano1, Stephanie San Martin1, Stephen Girgis1
1Department of Graduate Medical Education, Nicklaus Children's Hospital, Miami, Florida, USA.
Journal of the Pediatric Infectious Diseases Society
|July 28, 2021
Summary
Perimyocarditis cases were observed in 8 adolescents shortly after receiving the Pfizer-BioNTech COVID-19 vaccine (BNT162b2). This study details the clinical features of these rare vaccine side effects in young individuals.
Area of Science:
- Cardiology
- Vaccinology
- Pediatric Medicine
Background:
- The Pfizer-BioNTech COVID-19 vaccine (BNT162b2) received Emergency Use Authorization for adolescents on May 10, 2021.
- Myopericarditis is a known potential adverse event following certain vaccinations.
- Understanding the clinical presentation of perimyocarditis in adolescents post-vaccination is crucial for public health.
Purpose of the Study:
- To describe the clinical characteristics of adolescents who developed perimyocarditis after BNT162b2 vaccination.
- To analyze the temporal relationship between BNT162b2 vaccine administration and the onset of perimyocarditis symptoms.
Main Methods:
- Retrospective case series.
- Inclusion of 8 adolescent patients presenting with perimyocarditis within 4 days of BNT162b2 vaccination.
- Review of clinical data and diagnostic findings at Nicklaus Children's Hospital.
Main Results:
- Eight adolescent cases of perimyocarditis were identified within a 36-day period.
- All cases occurred within four days of receiving a dose of the BNT162b2 vaccine.
- Detailed clinical characteristics of these patients were documented.
Conclusions:
- Perimyocarditis is a rare clinical event observed in adolescents following BNT162b2 vaccination.
- The findings highlight the importance of monitoring for cardiac adverse events post-vaccination in pediatric populations.
- Further research is warranted to fully understand the pathophysiology and long-term outcomes.
More Related Videos
08:56Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
2.8K
12:24Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
10.1K
Related Concept Videos
01:14Myocarditis III: Medical Management
39
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
39
01:21Myocarditis I: Introduction
96
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
96
01:27Myocarditis II: Clinical Features and Diagnostic Tests
58
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
58
01:22Pericarditis I: Introduction
66
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
66
01:25Endocarditis I: Introduction
88
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
88
01:22Myocarditis IV: Nursing Management
64
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
64